BD GENERICS ApS: Financial statements 2017
CVR: 28707207
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
BD GENERICS ApS (CVR 28707207) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 41,998 and a net result of DKK 30,863 compared with DKK 31,328 the year before. That is an increase of 2.2% compared with the year before. Equity in the 2017 report amounted to DKK 957,326. The solvency ratio was 94.8%.
- Gross Profit
- DKK 41,998
- Profit/Loss
- DKK 30,863
- Equity
- DKK 957,326
- Total Assets
- DKK 1,009,546
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 42 t. | 31 t. | 957 t. | - |
| 2016 | - | 41 t. | 31 t. | 926 t. | - |
| 2015 | - | 7 t. | 7 t. | 895 t. | - |
| 2014 | - | 151 t. | 116 t. | 888 t. | - |
| 2013 | - | 1.5 mio. | 1.2 mio. | 1.8 mio. | - |
Keep an eye on BD GENERICS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
BD GENERICS ApS has published its annual report for 2016. Gross profit came to DKK 41,110, and the net result was DKK 31,328.
About BD GENERICS ApS
BD GENERICS ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2005. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Gerner Jacobsen. The company is owned by TGJ HOLDING ApS. The company has 1 employee (2009). In 2025, the company reported a gross profit of DKK -117,586 and a net result of DKK -64,678 compared with DKK -61,196 the year before. Equity in the 2025 report amounted to DKK 638,280.